Anzeige
Mehr »
Freitag, 03.07.2026 - Börsentäglich über 12.000 News
KI hat das Bohrziel gewählt - startet jetzt die nächste große Kupfer-Story aus Nevada?
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: 853849 | ISIN: JP3463000004 | Ticker-Symbol: TKD
Tradegate
02.07.26 | 21:48
29,000 Euro
0,00 % 0,000
Branche
Chemie
Aktienmarkt
NIKKEI-225
Singapur
1-Jahres-Chart
TAKEDA PHARMACEUTICAL CO LTD Chart 1 Jahr
5-Tage-Chart
TAKEDA PHARMACEUTICAL CO LTD 5-Tage-Chart
RealtimeGeldBriefZeit
28,75029,22002.07.
28,70029,30002.07.

Aktuelle News zur TAKEDA PHARMACEUTICAL Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
TAKEDA PHARMACEUTICAL Aktie jetzt für 0€ handeln
DoTakeda Makes Fresh AI Drug Discovery Bet With Insilico Medicine8
DoTakeda, Insilico sign AI drug discovery pact worth up to $600M3
DoInsilico Medicine, Takeda partner on AI-driven drug discovery7
DoInsilico Medicine Announces Collaboration with Takeda to Advance Strategic AI Drug Discovery114Partnership to leverage Pharma.AI platform for novel drug candidates across Takeda's therapeutic areas CAMBRIDGE, Mass., July 1, 2026 /PRNewswire/ -- Insilico Medicine...
► Artikel lesen
DoINSILICO Opens 10.75% Higher After Inking USD600M AI-powered Drug Discovery Strategic Partnership with Takeda9
MoTAKEDA PHARMACEUTICAL COMPANY LIMITED: GENERAL ANNOUNCEMENT::ARTICLES OF INCORPORATION9
26.06.Alkermes' incoming CEO has a plan to outplay Lilly and Takeda20
26.06.TAKEDA PHARMACEUTICAL COMPANY LIMITED: GENERAL ANNOUNCEMENT::RESULTS OF THE EXERCISE OF VOTING RIGHTS OF THE 150TH ANNUAL GENERAL MEETING OF SHAREHOLDERS4
26.06.Takeda sees return to growth within three years, new CEO says26
24.06.Julie Kim Takes Helm as Takeda CEO13
24.06.TAKEDA PHARMACEUTICAL COMPANY LIMITED: GENERAL ANNOUNCEMENT::2026 ANNUAL INTEGRATED REPORT2
24.06.TAKEDA PHARMACEUTICAL COMPANY LIMITED: GENERAL ANNOUNCEMENT::TAKEDA ANNOUNCES NEW ASSIGNMENTS OF DIRECTORS AND APPOINTMENT OF NEW CEO2
24.06.TAKEDA PHARMACEUTICAL COMPANY LIMITED: GENERAL ANNOUNCEMENT::NOTICE OF RESOLUTIONS AT THE 150TH ANNUAL GENERAL MEETING OF SHAREHOLDERS4
24.06.TAKEDA PHARMACEUTICAL CO LTD - 6-K, Report of foreign issuer5
24.06.Takeda Names Julie Kim CEO As Christophe Weber Retires508TOKYO (dpa-AFX) - Takeda Pharmaceutical Co. Ltd. (TAK, 4502.T) announced on Wednesday that it has appointed Julie Kim as President and CEO, completing an 18-month leadership transition.Former...
► Artikel lesen
24.06.Takeda finalizes 18-month transition: Julie Kim officially appointed President & CEO21
24.06.Takeda appoints Julie Kim as president and CEO9
24.06.Takeda ernennt Julie Kim zur neuen President und CEO7
23.06.Beim Pharmakonzern Takeda wackeln rund 200 Jobs in Wien34
23.06.Takeda Canada Announces Positive Topline Results For Phase 3 LATITUDE Atlas Study For Psoriasis377OTTAWA (dpa-AFX) - Takeda Canada, Inc., a Canadian subsidiary of Japan's Takeda Pharmaceutical Co. Ltd. (TAK), announced Tuesday positive topline results for the Phase 3, randomized, multicenter...
► Artikel lesen
Weiter >>
177 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1